Vaccines
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT04519073
Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 7, 2020
Completion: Mar 2, 2022
NCT06975319
Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers
Phase: Early Phase 1
Start: Jan 29, 2025
Completion: Jul 30, 2026
Loading map...